Looks like this $5.1m could be CLI partner upfront after presentation today we have started planning a phase 2 trial.
Trial set up H2 2018
Recruit H1 2019
It's a bigger market opportunity than GvHD by 4-5x
This is where the business model really starts to throw out huge numbers.
So GvHD is worth potentially $40m pa, and it's a royalty model.
say 50% falls to bottom line when in commercial production.
PE 20x (SaaS model)
GvHD value $400m
Also add the recent CTM Foot Ulcer JV likely to go to Phase 2, and I believe this would be a seperate target to CLI
now you can start to see how the cap can build with multiple targets next 2-5 years
- Forums
- ASX - By Stock
- CYP
- Shaw and Partners Research Update
Shaw and Partners Research Update, page-7
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $42.45M |
Open | High | Low | Value | Volume |
24.0¢ | 24.0¢ | 23.5¢ | $9.79K | 41.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3942 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 35000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3942 | 0.235 |
1 | 10000 | 0.230 |
2 | 50000 | 0.225 |
4 | 50237 | 0.220 |
2 | 14130 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 35000 | 1 |
0.270 | 70000 | 1 |
0.275 | 30000 | 1 |
0.280 | 60983 | 2 |
0.295 | 25028 | 2 |
Last trade - 14.18pm 14/10/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online